Syantra Revenue and Competitors
Estimated Revenue & Valuation
- Syantra's estimated annual revenue is currently $3.1M per year.
- Syantra's estimated revenue per employee is $155,000
Employee Data
- Syantra has 20 Employees.
- Syantra grew their employee count by 33% last year.
Syantra's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & Lead Scientist | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | VP, Business Development | Reveal Email/Phone |
4 | Chief Operations Officer | Reveal Email/Phone |
5 | Data Scientist & Software Developer | Reveal Email/Phone |
6 | Medical Director | Reveal Email/Phone |
7 | Executive Chair & Chief Financial Officer | Reveal Email/Phone |
8 | Senior Scientist, Molecular Discovery | Reveal Email/Phone |
9 | Healthcare Consultant | Reveal Email/Phone |
Syantra Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $3.6M | 46 | 7% | $1.7M | N/A |
#3 | $2.5M | 32 | 14% | N/A | N/A |
#4 | $3.4M | 44 | -4% | N/A | N/A |
#5 | $11.8M | 76 | 41% | N/A | N/A |
#6 | $3.6M | 23 | -4% | N/A | N/A |
#7 | $1.2M | 16 | 0% | N/A | N/A |
#8 | $4.5M | 29 | -9% | N/A | N/A |
#9 | $3.1M | 20 | 33% | N/A | N/A |
#10 | $0.7M | 9 | -25% | N/A | N/A |
What Is Syantra?
With a cancer diagnosis, early detection means better outcomes. It means hope. But when it comes to breast cancer, more than half of women have a reduced opportunity for an early, life-saving diagnosis. That's why we're developing Syantra DX: a blood test to detect breast cancer. It's a revolutionary, rapid, economical approach to breast cancer screening that's accurate regardless of the test recipient's family history, age or tissue density. We're working to improve the odds.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 20 | 25% | N/A |
#2 | $3.4M | 20 | 25% | N/A |
#3 | $3.1M | 21 | -12% | N/A |
#4 | $2.6M | 21 | 11% | N/A |
#5 | $3.3M | 21 | 11% | N/A |